Cargando…
Mining the mutanome: developing highly personalized Immunotherapies based on mutational analysis of tumors
T cells can mediate remarkable tumor regressions including complete cure in patients with metastatic cancer. Genetic alterations in an individual’s cancer cells (the mutanome) encode unique peptides (m-peptides) that can be targets for T cells. The recent advances in next-generation sequencing and c...
Autores principales: | Overwijk, Willem W, Wang, Ena, Marincola, Francesco M, Rammensee, Hans-Georg, Restifo, Nicholas P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019909/ https://www.ncbi.nlm.nih.gov/pubmed/24829748 http://dx.doi.org/10.1186/2051-1426-1-11 |
Ejemplares similares
-
Targeting the tumor mutanome for personalized vaccination therapy
por: Kreiter, Sebastian, et al.
Publicado: (2012) -
Mutanome Engineered RNA Immunotherapy: Towards Patient-Centered Tumor Vaccination
por: Vormehr, Mathias, et al.
Publicado: (2015) -
Peptide libraries for comprehensive coverage of the tumor mutanome in immune monitoring and immunotherapy
por: Castro, Aaron, et al.
Publicado: (2015) -
Targeting the tumor mutanome for personalized vaccination in a TMB low non-small cell lung cancer
por: McCann, Katy, et al.
Publicado: (2022) -
Peptide libraries for the comprehensive coverage of the tumor mutanome for immune monitoring and immuno therapy
por: von Hoegen, Paul, et al.
Publicado: (2015)